Tuesday, February 17, 2026 2/17/2026

Brown adipose tissue fructose metabolism

Award Number: R01DK135542
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/20/2023
PERIOD OF PERFORMANCE END DATE: 11/30/2028

Group Awards By:

View Award Description

Brown adipose tissue fructose metabolism - Project Summary Chronic overconsumption of high fructose-containing food and beverages has emerged as a significant risk factor for development of obesity, nonalcoholic fatty liver disease, and type 2 diabetes mellitus. Fructose metabolism has been extensively investigated in the hepatocyte, where 50-70% of dietary fructose is metabolized as well as in the small intestine and kidneys, where the fructose transporter Glut5 is highly expressed. However, much less is known in other metabolic organs including skeletal muscle, brain and white adipose tissue. Thus far, the impact of Glut5 and fructose metabolism in intrascapular brown adipose tissue (iBAT) has not been investigated. While analyzing the diet/feeding-stimulated iBAT transcriptomes to gain mechanistic insights, we observed a dramatic but transient upregulation of facilitated glucose/fructose transporter type 5 (Glut5, [Slc2a5]) in iBAT as early as 1 h after feeding from both male and female C57BL/6J mice but not in antibiotic-treated mice. Consistently, we also observed similar Glut5 upregulation in differentiated human brown adipocytes after incubation with serum from fed mice. In addition, we also observed that chronic high fructose consumption dysregulates iBAT basal Glut5 expression. This is unexpected because Glut5 expression in white fat is fructose-independent. Our data showed for the first time that iBAT Glut5 regulates circulating fructose homeostasis and mediates fructose-dependent iBAT whitening and obesity. Fructose metabolism is important for glycogen and lipid accumulation in hepatocyte. Increase in iBAT fructose metabolism due to fructose-induced Glut5 dysregulation could potentially leads to iBAT whitening. Together with our preliminary findings that feeding-induced Glut5 expression in iBAT is eliminated in antibiotic-treated mice, we hypothesize that high-fructose consumption promotes whitening and impairs iBAT metabolic activity via microbiome-dependent iBAT Glut5 expression. In this proposal, we plan to delineate how brown adipocyte Glut5 impacts iBAT metabolism. We will also determine whether high-fructose diet increase Glut5 via microbiota-derived hyodeoxycholic acid (HDCA) to inhibit iBAT function. Finally, we will determine liver-x-receptors (LXRs) expressed in brown adipocyte are required for whitening and metabolic activity impairment in iBAT induced by high-fructose diet. Successful completion of this proposed study will contribute to our understanding of high fructose diet-induced brown fat whitening and metabolic dysfunction.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $547,873 )
2026	2026	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	1/15/2026	NON-COMPETING CONTINUATION	$547,873
														Subtotal = $547,873

Issue Date FY: 2025 ( Subtotal = $531,180 )
2025	2025	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	11/22/2024	NON-COMPETING CONTINUATION	$478,063
2025	2025	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	2	6/13/2025	NON-COMPETING CONTINUATION	$53,117
														Subtotal = $531,180

Issue Date FY: 2024 ( Subtotal = $557,611 )
2024	2024	UNIVERSITY OF ILLINOIS	809 S MARSHFIELD AVE M/C 551	CHICAGO	IL	60612	COOK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	12/19/2023	NEW	$557,611
														Subtotal = $557,611

Grand Total All Awards = $1,636,664

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Brown adipose tissue fructose metabolism

Award Number: R01DK135542

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/20/2023

PERIOD OF PERFORMANCE END DATE: 11/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer